Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard D Dimarchi

Showing results (41-50 of 123) with videos related to

Pageof 13
Sort By:
Trends in Molecular Medicine|April 4, 2016
Reappraisal of GIP Pharmacology for Metabolic DiseasesBrian Finan, Timo D Müller, Christoffer Clemmensen, et al.
Nature Reviews. Endocrinology|November 18, 2018
Emerging hormonal-based combination pharmacotherapies for the treatment of metabolic diseasesChristoffer Clemmensen, Brian Finan, Timo D Müller, et al.
Journal of Medicinal Chemistry|August 11, 2016
Pyridyl-alanine as a Hydrophilic, Aromatic Element in Peptide Structural OptimizationPiotr A Mroz, Diego Perez-Tilve, Fa Liu, et al.
Bioorganic & Medicinal Chemistry|November 21, 2017
Optimization of peptide-based polyagonists for treatment of diabetes and obesityPatrick J Knerr, Brian Finan, Vasily Gelfanov, et al.
Peptides|December 2, 2019
Selection and progression of unimolecular agonists at the GIP, GLP-1, and glucagon receptors as drug candidatesPatrick J Knerr, Stephanie A Mowery, Brian Finan, et al.
Cell Metabolism|August 17, 2023
GIPR/GLP-1R dual agonist therapies for diabetes and weight loss-chemistry, physiology, and clinical applicationsJonathan E Campbell, Timo D Müller, Brian Finan, et al.
Molecular Metabolism|December 23, 2018
Optimized GIP analogs promote body weight lowering in mice through GIPR agonism not antagonismPiotr A Mroz, Brian Finan, Vasily Gelfanov, et al.
Molecular Metabolism|October 17, 2017
Gαs regulates Glucagon-Like Peptide 1 Receptor-mediated cyclic AMP generation at Rab5 endosomal compartmentShravan Babu Girada, Ramya S Kuna, Shilpak Bele, et al.
Diabetologia|July 23, 2017
GLP-1/glucagon receptor co-agonism for treatment of obesityMiguel A Sánchez-Garrido, Sara J Brandt, Christoffer Clemmensen, et al.
Cell Metabolism|July 14, 2016
Unimolecular Polypharmacy for Treatment of Diabetes and ObesityMatthias H Tschöp, Brian Finan, Christoffer Clemmensen, et al.
Pageof 13

Showing results (41-50 of 123) with videos related to

Sort By:
Pageof 13
Trends in Molecular Medicine|April 4, 2016
Reappraisal of GIP Pharmacology for Metabolic DiseasesBrian Finan, Timo D Müller, Christoffer Clemmensen, et al.
Nature Reviews. Endocrinology|November 18, 2018
Emerging hormonal-based combination pharmacotherapies for the treatment of metabolic diseasesChristoffer Clemmensen, Brian Finan, Timo D Müller, et al.
Journal of Medicinal Chemistry|August 11, 2016
Pyridyl-alanine as a Hydrophilic, Aromatic Element in Peptide Structural OptimizationPiotr A Mroz, Diego Perez-Tilve, Fa Liu, et al.
Bioorganic & Medicinal Chemistry|November 21, 2017
Optimization of peptide-based polyagonists for treatment of diabetes and obesityPatrick J Knerr, Brian Finan, Vasily Gelfanov, et al.
Peptides|December 2, 2019
Selection and progression of unimolecular agonists at the GIP, GLP-1, and glucagon receptors as drug candidatesPatrick J Knerr, Stephanie A Mowery, Brian Finan, et al.
Cell Metabolism|August 17, 2023
GIPR/GLP-1R dual agonist therapies for diabetes and weight loss-chemistry, physiology, and clinical applicationsJonathan E Campbell, Timo D Müller, Brian Finan, et al.
Molecular Metabolism|December 23, 2018
Optimized GIP analogs promote body weight lowering in mice through GIPR agonism not antagonismPiotr A Mroz, Brian Finan, Vasily Gelfanov, et al.
Molecular Metabolism|October 17, 2017
Gαs regulates Glucagon-Like Peptide 1 Receptor-mediated cyclic AMP generation at Rab5 endosomal compartmentShravan Babu Girada, Ramya S Kuna, Shilpak Bele, et al.
Diabetologia|July 23, 2017
GLP-1/glucagon receptor co-agonism for treatment of obesityMiguel A Sánchez-Garrido, Sara J Brandt, Christoffer Clemmensen, et al.
Cell Metabolism|July 14, 2016
Unimolecular Polypharmacy for Treatment of Diabetes and ObesityMatthias H Tschöp, Brian Finan, Christoffer Clemmensen, et al.
Pageof 13